按品牌選擇
 |
|
|||||||||||||||||||||||||||||||||
| [發(fā)表評(píng)論] [本類其他產(chǎn)品] [本類其他供應(yīng)商] [收藏] | ||||||||||||||||||||||||||||||||||
| 銷售商： 廣東固康生物科技有限公司 | 查看該公司所有產(chǎn)品 >> |
【產(chǎn)品名稱】
通用名稱：阿狄科®高敏色氨酸檢測(cè)試劑盒（酶聯(lián)免疫法）
英文名稱：IDK® Tryptophan High Sensitive (mouse/rat) ELISA
【預(yù)期用途】
產(chǎn)品用于定量測(cè)定嚙齒類動(dòng)物（小鼠、大鼠）中的EDTA血漿、血清和腦組織以及細(xì)胞培養(yǎng)上清液和腦脊液(CSF)中的L-色氨酸。僅供科研使用。不用于臨床診斷。
【包裝規(guī)格】
96人份/盒
【背景知識(shí)】
通用名稱：阿狄科®高敏色氨酸檢測(cè)試劑盒（酶聯(lián)免疫法）
英文名稱：IDK® Tryptophan High Sensitive (mouse/rat) ELISA
【預(yù)期用途】
產(chǎn)品用于定量測(cè)定嚙齒類動(dòng)物（小鼠、大鼠）中的EDTA血漿、血清和腦組織以及細(xì)胞培養(yǎng)上清液和腦脊液(CSF)中的L-色氨酸。僅供科研使用。不用于臨床診斷。
【包裝規(guī)格】
96人份/盒
【背景知識(shí)】
樣本要求：適用于嚙齒類動(dòng)物（小鼠、大鼠）的EDTA血漿和血清、細(xì)胞培養(yǎng)上清液和CSF（腦脊液）。
儲(chǔ)存條件：本產(chǎn)品在2-8℃下保存，可穩(wěn)定至標(biāo)簽所示日期。
參考文獻(xiàn)：
1. Brandacher G, Hoeller E, Fuchs D, Weiss HG. Chronic immune activation underlies morbid obesity: is IDO a key player. Curr Drug Metab. 2007; 8 (3): 289-95.
2. Chuang SC, Fanidi A, Ueland PM et al: Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):461-8.
3. Ciorba MA: Indoleamine 2,3 dioxygenase in intestinal disease. Curr Opin Gastroenterol. 2013 Mar;29(2):146-52.
4. Creelan BC, Antonia S, Bepler G, Garrett TJ, Simon GR, Soliman HH: Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III nonsmall cell lung cancer. Oncoimmunology. 2013 Mar 1;2(3):e23428.
5. Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, Stenson WF, Ciorba MA: Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflamm Bowel Dis. 2012 Jul;18(7):1214-20.
6. Murray C, Griffin ÉW, O’Loughlin E, Lyons A, Sherwin E, Ahmed S, Stevenson N J, et al. Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C. Brain, Behavior, and Immunity. 2015, 48: 274-286.
7. Suzuki Y, Suda T, Asada K, Miwa S, Suzuki M, Fujie M, Furuhashi K, Nakamura Y, Inui N, Shirai T, Hayakawa H, Nakamura H, Chida K: Serum Indoleamine 2,3- Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis. Clin Vaccine Immunol. 2012 March; 19(3): 436–442.
8. Yan EB, Frugier T, Lim CK, Heng B, Sundaram G, Tan M, Rosenfeld JV, et al. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. Journal of Neuroinflammation. 2015,12(1), 110.
儲(chǔ)存條件：本產(chǎn)品在2-8℃下保存，可穩(wěn)定至標(biāo)簽所示日期。
參考文獻(xiàn)：
1. Brandacher G, Hoeller E, Fuchs D, Weiss HG. Chronic immune activation underlies morbid obesity: is IDO a key player. Curr Drug Metab. 2007; 8 (3): 289-95.
2. Chuang SC, Fanidi A, Ueland PM et al: Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):461-8.
3. Ciorba MA: Indoleamine 2,3 dioxygenase in intestinal disease. Curr Opin Gastroenterol. 2013 Mar;29(2):146-52.
4. Creelan BC, Antonia S, Bepler G, Garrett TJ, Simon GR, Soliman HH: Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III nonsmall cell lung cancer. Oncoimmunology. 2013 Mar 1;2(3):e23428.
5. Gupta NK, Thaker AI, Kanuri N, Riehl TE, Rowley CW, Stenson WF, Ciorba MA: Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity. Inflamm Bowel Dis. 2012 Jul;18(7):1214-20.
6. Murray C, Griffin ÉW, O’Loughlin E, Lyons A, Sherwin E, Ahmed S, Stevenson N J, et al. Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C. Brain, Behavior, and Immunity. 2015, 48: 274-286.
7. Suzuki Y, Suda T, Asada K, Miwa S, Suzuki M, Fujie M, Furuhashi K, Nakamura Y, Inui N, Shirai T, Hayakawa H, Nakamura H, Chida K: Serum Indoleamine 2,3- Dioxygenase Activity Predicts Prognosis of Pulmonary Tuberculosis. Clin Vaccine Immunol. 2012 March; 19(3): 436–442.
8. Yan EB, Frugier T, Lim CK, Heng B, Sundaram G, Tan M, Rosenfeld JV, et al. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans. Journal of Neuroinflammation. 2015,12(1), 110.
原裝進(jìn)口產(chǎn)品, 質(zhì)量保證, 科研產(chǎn)品需配合提供商檢通關(guān)文件。收到貨后如有破損請(qǐng)于兩個(gè)工作日內(nèi)提出。請(qǐng)嚴(yán)格按照產(chǎn)品說(shuō)明書操作，如有質(zhì)量問(wèn)題時(shí)， 請(qǐng)?zhí)峁⿲?shí)驗(yàn)報(bào)告及詳細(xì)操作說(shuō)明， 并提供結(jié)果圖片， 試劑盒圖片及原始數(shù)據(jù)， 方便國(guó)外廠商調(diào)查。
手機(jī)版：阿狄科®高敏色氨酸檢測(cè)試劑盒
- 2024年腫瘤領(lǐng)域十大年度事件匯總
- B細(xì)胞前體急性淋巴細(xì)胞白血病在骨髓間充質(zhì)基質(zhì)中引發(fā)干擾素α/β反應(yīng)
- 瘦素ELISA（超靈敏）試劑盒檢測(cè)原理及樣本和標(biāo)準(zhǔn)曲線數(shù)據(jù)分析
- 人細(xì)胞色素P450 4A11（CYP4A11）ELISA檢測(cè)試劑盒使用說(shuō)明書
- 果蠅DNA甲基轉(zhuǎn)移酶（DNMT）ELISA檢測(cè)試劑盒使用說(shuō)明書
- 抗體親和提取(AAE™)：革新宿主細(xì)胞蛋白(HCPs)分析的新篇章
- 斑馬魚淀粉樣前體蛋白（APP）ELISA檢測(cè)試劑盒使用說(shuō)明書
- 人adropin（AD）ELISA檢測(cè)試劑盒使用說(shuō)明書
Copyright(C) 1998-2025 生物器材網(wǎng) 電話：021-64166852;13621656896 E-mail：info@bio-equip.com